Table of Content

Table of Contents



Global Kidney Cancer Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope

1.1 Product Details and Introduction

1.1.1 Nexavar (Sorafenib) -Product Introduction and Major Manufacturers

1.1.2 Sutent (Sunitinib) -Product Introduction and Major Manufacturers

1.1.3 Afinitor (Everolimus) -Product Introduction and Major Manufacturers

1.1.4 Votrient (Pazopanib) -Product Introduction and Major Manufacturers

1.1.5 Avastin (Bevacizumab) -Product Introduction and Major Manufacturers

1.1.6 Inlyta (Axitinib) -Product Introduction and Major Manufacturers

1.1.7 Torisel (Temsirolimus) -Product Introduction and Major Manufacturers

1.1.8 Proleukin (Aldesleukin) -Product Introduction and Major Manufacturers

1.1.9 Other -Product Introduction and Major Manufacturers

1.2 Market Snapshot

1.2.1 Major Companies Overview

1.2.2 Market Concentration

1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market

2.1 Regional Market Share in Terms of Production (2019-2026)

2.2 Regional Market Share in Terms of Revenue (2019-2026)

2.3 Regional Market Share in Terms of Consumption (2019-2026)

3 Global Kidney Cancer Drugs Market Assessment by Type

3.1 Global Kidney Cancer Drugs Production by Type (2015-2026)

3.2 Global Kidney Cancer Drugs Revenue by Type (2015-2026)

3.3 North America Kidney Cancer Drugs Production and Revenue by Type (2015-2026)

3.4 Asia Kidney Cancer Drugs Production and Revenue by Type (2015-2026)

3.5 Europe Kidney Cancer Drugs Production and Revenue by Type (2015-2026)

3.6 Middle East & Africa Kidney Cancer Drugs Production and Revenue by Type (2015-2026)

3.7 South America Kidney Cancer Drugs Production and Revenue by Type (2015-2026)



4 Global Kidney Cancer Drugs Market Assessment by Application

4.1 Historical & Forecast Global Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)

4.2 Historical & Forecast North America Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)

4.3 Historical & Forecast Asia Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)

4.4 Historical & Forecast Europe Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)

4.5 Historical & Forecast Middle East & Africa Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)

4.6 Historical & Forecast South America Kidney Cancer Drugs Consumption, Different Application Field (2015-2026)



5 North America

5.1 US Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.2 Canada Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.3 Mexico Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6 Asia

6.1 China Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.2 Japan Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.3 India Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.4 Korea Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.5 Southeat Asia Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7 Europe

7.1 Germany Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.2 UK Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.3 France Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.4 Russia Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.5 Italy Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8 Middle East and Africa

8.1 Saudi Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.2 UAE Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.3 Egypt Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.4 Nigeria Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.5 South Africa Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9 South America

9.1 Brazil Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.2 Argentina Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.3 Colombia Kidney Cancer Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

10 Global Kidney Cancer Drugs Average Price Trend

10.1 Market Price for Each Type of Kidney Cancer Drugs in North America (2015-2026)

10.2 Market Price for Each Type of Kidney Cancer Drugs in Asia (2015-2026)

10.3 Market Price for Each Type of Kidney Cancer Drugs in Europe (2015-2026)

10.4 Market Price for Each Type of Kidney Cancer Drugs in Middle East & Africa (2015-2026)

10.5 Market Price for Each Type of Kidney Cancer Drugs in South America (2015-2026)



11 Value Chain (Impact of COVID-19)

11.1 Kidney Cancer Drugs Value Chain Analysis

11.1.1 Upstream

11.1.2 Downstream

11.2 COVID-19 Impact on Kidney Cancer Drugs Industry

11.2.1 Industrial Policy Issued Under the Epidemic Situation

11.3 Cost-Under the Epidemic Situation

11.3.1 Cost of Raw Material

11.4 Channel Analysis

11.4.1 Distribution Channel-Under the Epidemic Situation

11.4.2 Distributors



12 Kidney Cancer Drugs Competitive Analysis

12.1 Pfizer

12.1.1 Pfizer Company Profiles

12.1.2 Pfizer Product Introduction

12.1.3 Pfizer Kidney Cancer Drugs Production, Revenue (2015-2020)

12.1.4 SWOT Analysis

12.2 Abbott Laboratories

12.2.1 Abbott Laboratories Company Profiles

12.2.2 Abbott Laboratories Product Introduction

12.2.3 Abbott Laboratories Kidney Cancer Drugs Production, Revenue (2015-2020)

12.2.4 SWOT Analysis

12.3 Glaxosmithkline PLC

12.3.1 Glaxosmithkline PLC Company Profiles

12.3.2 Glaxosmithkline PLC Product Introduction

12.3.3 Glaxosmithkline PLC Kidney Cancer Drugs Production, Revenue (2015-2020)

12.3.4 SWOT Analysis

12.4 Novartis AG

12.4.1 Novartis AG Company Profiles

12.4.2 Novartis AG Product Introduction

12.4.3 Novartis AG Kidney Cancer Drugs Production, Revenue (2015-2020)

12.4.4 SWOT Analysis

12.5 F. Hoffmann-La Roche

12.5.1 Bayer AG Company Profiles

12.5.2 Bayer AG Product Introduction

12.5.3 Bayer AG Kidney Cancer Drugs Production, Revenue (2015-2020)

12.5.4 SWOT Analysis

12.6 Active Biotech

12.6.1 Active Biotech Company Profiles

12.6.2 Active Biotech Product Introduction

12.6.3 Active Biotech Kidney Cancer Drugs Production, Revenue (2015-2020)

12.6.4 SWOT Analysis

12.7 Amgen

12.7.1 Amgen Company Profiles

12.7.2 Amgen Product Introduction

12.7.3 Amgen Kidney Cancer Drugs Production, Revenue (2015-2020)

12.7.4 SWOT Analysis

12.8 Cipla Limited

12.8.1 Cipla Limited Company Profiles

12.8.2 Cipla Limited Product Introduction

12.8.3 Cipla Limited Kidney Cancer Drugs Production, Revenue (2015-2020)

12.8.4 SWOT Analysis

12.9 F. Hoffmann-La Roche

12.9.1 F. Hoffmann-La Roche Company Profiles

12.9.2 F. Hoffmann-La Roche Product Introduction

12.9.3 F. Hoffmann-La Roche Kidney Cancer Drugs Production, Revenue (2015-2020)

12.9.4 SWOT Analysis

12.10 Genentech

12.10.1 Genentech Company Profiles

12.10.2 Genentech Product Introduction

12.10.3 Genentech Kidney Cancer Drugs Production, Revenue (2015-2020)

12.10.4 SWOT Analysis

12.11 Prometheus Laboratories

12.12 Exelixis

12.13 Onyx Pharmaceuticals

12.14 Aveo Pharmaceuticals

12.15 Immatics Biotechnologies

13 Conclusion

List of Figure

List of Tables and Figures



Figure Product Introduction

Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)

Figure Global Kidney Cancer Drugs Production Market Share of Top 5 Players

Table CAGR of Major Market (2021-2026)

Table CAGR in Terms of Production of Each Type (2015-2026)

Table Regional Market Share in Terms of Production (2019-2026)

Figure Regional Market Share in Terms of Production (2019 - 2020)

Table Regional Market Share in Terms of Revenue (2019-2026)

Figure Regional Market Share in Terms of Revenue (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Table Global Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure Global Kidney Cancer Drugs Production Market Share (%) by Type (2019 -2020)

Table Global Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Figure Global Kidney Cancer Drugs Revenue Market Share (%) by Type (2019-2020)

Figure North America Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure North America Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure North America Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure North America Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Figure Asia Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure Asia Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure Asia Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure Asia Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Figure Europe Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure Europe Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure Europe Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure Europe Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Figure Middle East & Africa Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure Middle East & Africa Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure Middle East & Africa Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Figure South America Kidney Cancer Drugs Production (K Unit) by Type (2015-2026)

Figure South America Kidney Cancer Drugs Production (K Unit) and Growth Rate (2015-2026)

Figure South America Kidney Cancer Drugs Revenue (Million USD) by Type (2015-2026)

Figure South America Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure Consumption (K Unit) and Growth Rate (2015-2026)

Figure Different Application Field Consumption Market Share (%) (2019-2020)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure North America Kidney Cancer Drugs Consumption (K Unit) and Growth Rate (2015-2026)

Figure North America Kidney Cancer Drugs Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure Asia Kidney Cancer Drugs Consumption (K Unit) and Growth Rate (2015-2026)

Figure Asia Kidney Cancer Drugs Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure Europe Kidney Cancer Drugs Consumption (K Unit) and Growth Rate (2015-2026)

Figure Europe Kidney Cancer Drugs Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure Middle East & Africa Kidney Cancer Drugs Consumption (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Kidney Cancer Drugs Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Figure South America Kidney Cancer Drugs Consumption (K Unit) and Growth Rate (2015-2026)

Figure South America Kidney Cancer Drugs Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Kidney Cancer Drugs Different Application Field Consumption (K Unit)

Table US Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Canada Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Mexico Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table China Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Japan Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table India Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Korea Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Southeast Asia Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Germany Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UK Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table France Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Russia Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Italy Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Saudi Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UAE Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Egypt Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Nigeria Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table South Africa Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Brazil Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Argentina Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Colombia Kidney Cancer Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in China

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in EU

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in USA

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in Japan

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in India

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in Southeast Asia

Table Market Price (USD/Unit) for Each Type of Kidney Cancer Drugs in South America

Figure Value Chain Structure of Kidney Cancer Drugs

Table Value Chain

Table Key Suppliers of Raw Material/Components

Table Key Downstream Customer in Each Application Field

Table Industry News List of Kidney Cancer Drugs

Figure Cost Structure of Kidney Cancer Drugs in 2020

Table Distributors/Traders List

Table Pfizer Profiles

Table Pfizer Kidney Cancer Drugs Product Introduction

Figure Pfizer Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Pfizer SWOT Analysis

Table Abbott Laboratories Profiles

Table Abbott Laboratories Kidney Cancer Drugs Product Introduction

Figure Abbott Laboratories Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Abbott Laboratories SWOT Analysis

Table Glaxosmithkline PLC Profiles

Table Glaxosmithkline PLC Kidney Cancer Drugs Product Introduction

Figure Glaxosmithkline PLC Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Glaxosmithkline PLC SWOT Analysis

Table Novartis AG Profiles

Table Novartis AG Kidney Cancer Drugs Product Introduction

Figure Novartis AG Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Novartis AG SWOT Analysis

Table Bayer AG Profiles

Table Bayer AG Kidney Cancer Drugs Product Introduction

Figure Bayer AG Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Bayer AG SWOT Analysis

Table Active Biotech Profiles

Table Active Biotech Kidney Cancer Drugs Product Introduction

Figure Active Biotech Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Active Biotech SWOT Analysis

Table Amgen Profiles

Table Amgen Kidney Cancer Drugs Product Introduction

Figure Amgen Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Amgen SWOT Analysis

Table Cipla Limited Profiles

Table Cipla Limited Kidney Cancer Drugs Product Introduction

Figure Cipla Limited Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Cipla Limited SWOT Analysis

Table F. Hoffmann-La Roche Profiles

Table F. Hoffmann-La Roche Kidney Cancer Drugs Product Introduction

Figure F. Hoffmann-La Roche Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure F. Hoffmann-La Roche SWOT Analysis

Table Genentech Profiles

Table Genentech Kidney Cancer Drugs Product Introduction

Figure Genentech Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Genentech SWOT Analysis

Table Prometheus Laboratories Profiles

Table Prometheus Laboratories Kidney Cancer Drugs Product Introduction

Figure Prometheus Laboratories Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Prometheus Laboratories SWOT Analysis

Table Exelixis Profiles

Table Exelixis Kidney Cancer Drugs Product Introduction

Figure Exelixis Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Exelixis SWOT Analysis

Table Onyx Pharmaceuticals Profiles

Table Onyx Pharmaceuticals Kidney Cancer Drugs Product Introduction

Figure Onyx Pharmaceuticals Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Onyx Pharmaceuticals SWOT Analysis

Table Aveo Pharmaceuticals Profiles

Table Aveo Pharmaceuticals Kidney Cancer Drugs Product Introduction

Figure Aveo Pharmaceuticals Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Aveo Pharmaceuticals SWOT Analysis

Table Immatics Biotechnologies Profiles

Table Immatics Biotechnologies Kidney Cancer Drugs Product Introduction

Figure Immatics Biotechnologies Kidney Cancer Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)